Cyclobenzaprine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00924 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 71 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | myofascial pain syndrome | KG + DL |
| 2 | neuralgia | KG + DL |
| 3 | papillary conjunctivitis | KG + DL |
| 4 | migraine disorder | KG + DL |
| 5 | migraine with brainstem aura | KG + DL |
| 6 | cauda equina syndrome | KG + DL |
| 7 | sciatic neuropathy | KG + DL |
| 8 | glossodynia | KG + DL |
| 9 | coccygodynia | KG + DL |
| 10 | dysthymic disorder | KG + DL |
| 11 | anaphylaxis | KG + DL |
| 12 | anxiety disorder | KG + DL |
| 13 | angioedema | KG + DL |
| 14 | headache disorder | KG + DL |
| 15 | benign paroxysmal torticollis of infancy | KG + DL |
| 16 | obsolete neurogenic bladder (disease) | KG + DL |
| 17 | myositis fibrosa | KG + DL |
| 18 | idiopathic granulomatous myositis | KG + DL |
| 19 | tendinitis | KG + DL |
| 20 | migraine with or without aura, susceptibility to | KG + DL |
| 21 | fibromyalgia | KG + DL |
| 22 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 23 | agoraphobia | KG + DL |
| 24 | atrophoderma vermiculata | KG + DL |
| 25 | rosacea conjunctivitis | KG + DL |
| 26 | trigeminal autonomic cephalalgia | KG + DL |
| 27 | inclusion body myositis | KG + DL |
| 28 | atopic conjunctivitis | KG + DL |
| 29 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 30 | ulerythema ophryogenesis | KG + DL |
| 31 | combined hyperactive dysfunction syndrome of the cranial nerves | KG + DL |
| 32 | facial neuralgia | KG + DL |
| 33 | common cold | KG + DL |
| 34 | obsolete vascular headache | KG + DL |
| 35 | allergic asthma | KG + DL |
| 36 | intrinsic asthma | KG + DL |
| 37 | anxiety | KG + DL |
| 38 | attention deficit-hyperactivity disorder | KG + DL |
| 39 | rhinitis | KG + DL |
| 40 | specific developmental disorder | KG + DL |
| 41 | asthma-related traits, susceptibility to | KG + DL |
| 42 | pseudoallergy | KG + DL |
| 43 | insomnia (disease) | KG + DL |
| 44 | chondromyxoid fibroma | KG + DL |
| 45 | bronchial disease | KG + DL |
| 46 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 47 | cold urticaria | KG + DL |
| 48 | faciodigitogenital syndrome | KG + DL |
| 49 | obsessive-compulsive disorder | KG + DL |
| 50 | Ohdo syndrome and variants | KG + DL |
(Showing top 50 of 71 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.